Results were in line with expectations as per previous call. Seq revenue is up 10% and EBIDTA is up from 13.7% to 15.8%. Q3 Con call will give more details on composition, outlook and any development.
Subscribe To Our Free Newsletter |
Results were in line with expectations as per previous call. Seq revenue is up 10% and EBIDTA is up from 13.7% to 15.8%. Q3 Con call will give more details on composition, outlook and any development.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!